• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻成年人骨质疏松症管理中的困境

Dilemmas in the Management of Osteoporosis in Younger Adults.

作者信息

Herath Madhuni, Cohen Adi, Ebeling Peter R, Milat Frances

机构信息

Department of Endocrinology Monash Health Clayton Victoria Australia.

Centre for Endocrinology & Metabolism Hudson Institute of Medical Research Clayton Victoria Australia.

出版信息

JBMR Plus. 2022 Jan 19;6(1):e10594. doi: 10.1002/jbm4.10594. eCollection 2022 Jan.

DOI:10.1002/jbm4.10594
PMID:35079682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8771004/
Abstract

Osteoporosis in premenopausal women and men younger than 50 years is challenging to diagnose and treat. There are many barriers to optimal management of osteoporosis in younger adults, further enhanced by a limited research focus on this cohort. Herein we describe dilemmas commonly encountered in diagnosis, investigation, and management of osteoporosis in younger adults. We also provide a suggested framework, based on the limited available evidence and supported by clinical experience, for the diagnosis, assessment, and management of osteoporosis in this cohort. © 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

摘要

绝经前女性和50岁以下男性的骨质疏松症诊断和治疗颇具挑战。年轻成年人骨质疏松症的最佳管理存在诸多障碍,而针对这一人群的研究重点有限,这进一步加剧了这些障碍。在此,我们描述了年轻成年人骨质疏松症诊断、检查和管理中常见的困境。我们还基于有限的现有证据并结合临床经验,提供了一个针对该人群骨质疏松症诊断、评估和管理的建议框架。© 2021作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/8771004/84c916f517ac/JBM4-6-e10594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/8771004/5a1e1ad77b39/JBM4-6-e10594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/8771004/84c916f517ac/JBM4-6-e10594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/8771004/5a1e1ad77b39/JBM4-6-e10594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d19/8771004/84c916f517ac/JBM4-6-e10594-g001.jpg

相似文献

1
Dilemmas in the Management of Osteoporosis in Younger Adults.年轻成年人骨质疏松症管理中的困境
JBMR Plus. 2022 Jan 19;6(1):e10594. doi: 10.1002/jbm4.10594. eCollection 2022 Jan.
2
Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?降低高龄老人骨折风险的药物干预措施:证据有哪些?
JBMR Plus. 2021 Sep 5;5(10):e10538. doi: 10.1002/jbm4.10538. eCollection 2021 Oct.
3
Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study.利用低剂量 CT 进行机会性筛查与中国骨质疏松症的患病率:一项全国性、多中心研究。
J Bone Miner Res. 2021 Mar;36(3):427-435. doi: 10.1002/jbmr.4187. Epub 2020 Nov 4.
4
Bisphosphonate Use and Fractures in Adults with Hypophosphatasia.低磷酸酯酶症成人患者中双膦酸盐的使用与骨折情况
JBMR Plus. 2019 Aug 26;3(10):e10223. doi: 10.1002/jbm4.10223. eCollection 2019 Oct.
5
Factors Associated With Adherence to Osteoporosis Medications Among Male Veterans.男性退伍军人中与骨质疏松症药物依从性相关的因素
JBMR Plus. 2021 Jun 30;5(8):e10498. doi: 10.1002/jbm4.10498. eCollection 2021 Aug.
6
Estimating the Effect of Elagolix Treatment for Endometriosis on Postmenopausal Bone Outcomes: A Model Bridging Phase III Trials to an Older Real-World Population.评估艾拉戈利克治疗子宫内膜异位症对绝经后骨骼结局的影响:一个将III期试验与老年真实世界人群相联系的模型。
JBMR Plus. 2020 Nov 7;4(12):e10401. doi: 10.1002/jbm4.10401. eCollection 2020 Dec.
7
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years.使用双膦酸盐治疗1至14年的骨质疏松症女性的骨质量与骨折情况
JBMR Plus. 2021 Sep 21;5(11):e10549. doi: 10.1002/jbm4.10549. eCollection 2021 Nov.
8
A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis.在一名患有严重骨质疏松症的年轻男性中发现的一种新型RUNX1基因变异体。
JBMR Plus. 2023 Jul 29;7(9):e10791. doi: 10.1002/jbm4.10791. eCollection 2023 Sep.
9
Failure of Oral Risedronate Therapy to Prevent Spontaneous Vertebral Fracture in a Patient Ceasing Denosumab: A Cautionary Case.口服利塞膦酸盐治疗未能预防停用地诺单抗患者的自发性椎体骨折:一则警示案例
JBMR Plus. 2020 Aug 21;4(10):e10396. doi: 10.1002/jbm4.10396. eCollection 2020 Oct.
10
Engagement in Primary Prevention Program among Rural Veterans With Osteoporosis Risk.骨质疏松症风险农村退伍军人参与初级预防项目情况
JBMR Plus. 2022 Oct 3;6(10):e10682. doi: 10.1002/jbm4.10682. eCollection 2022 Oct.

引用本文的文献

1
Fragility Fracture: 10 Commandments.脆性骨折:十条戒律。
Indian J Orthop. 2025 Mar 27;59(3):244-255. doi: 10.1007/s43465-025-01356-y. eCollection 2025 Mar.
2
Two families, two pathways: a case series of 46, XY DSD with 17α-hydroxylase deficiency and isolated 17,20-lyase deficiency due to novel variant.两个家族,两条途径:46,XY性发育障碍伴17α-羟化酶缺乏症和因新变异导致的孤立性17,20-裂解酶缺乏症的病例系列
J Pediatr Endocrinol Metab. 2025 Mar 25;38(6):649-657. doi: 10.1515/jpem-2024-0613. Print 2025 Jun 26.
3
'Bone Health-Across a Woman's Lifespan'.

本文引用的文献

1
Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.全外显子组测序揭示了一小部分特发性骨质疏松症的绝经前女性中潜在致病性的变异。
Bone. 2022 Jan;154:116253. doi: 10.1016/j.bone.2021.116253. Epub 2021 Nov 4.
2
Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer.评估早期乳腺癌辅助用地舒单抗的国际、多中心、随机、3 期、安慰剂对照 D-CARE 研究中的骨骼健康结局。
Adv Ther. 2021 Aug;38(8):4569-4580. doi: 10.1007/s12325-021-01812-9. Epub 2021 Jun 29.
3
《女性一生的骨骼健康》
Clin Endocrinol (Oxf). 2025 Apr;102(4):389-402. doi: 10.1111/cen.15203. Epub 2025 Jan 27.
4
The impact of an online support group on patients' awareness of pregnancy-and lactation-induced osteoporosis.在线支持小组对患者妊娠和哺乳期骨质疏松症意识的影响。
BMC Pregnancy Childbirth. 2024 Nov 30;24(1):807. doi: 10.1186/s12884-024-07004-x.
5
Hand Grip Strength, Osteoporosis, and Quality of Life in Middle-Aged and Older Adults.手握力、骨质疏松症与中老年人群的生活质量。
Medicina (Kaunas). 2023 Dec 11;59(12):2148. doi: 10.3390/medicina59122148.
6
Different cervical vertebral bone quality scores for bone mineral density assessment for the patients with cervical degenerative disease undergoing ACCF/ACDF: computed tomography and magnetic resonance imaging-based study.用于评估接受 ACCF/ACDF 的颈椎退行性疾病患者骨密度的不同颈椎骨质量评分:基于 CT 和 MRI 的研究。
J Orthop Surg Res. 2023 Dec 6;18(1):927. doi: 10.1186/s13018-023-04422-z.
7
A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis.在一名患有严重骨质疏松症的年轻男性中发现的一种新型RUNX1基因变异体。
JBMR Plus. 2023 Jul 29;7(9):e10791. doi: 10.1002/jbm4.10791. eCollection 2023 Sep.
8
A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.全基因组遗传评分添加到标准推荐的分层工具中并不能提高极低骨密度患者的识别率。
Osteoporos Int. 2023 Nov;34(11):1893-1906. doi: 10.1007/s00198-023-06857-w. Epub 2023 Jul 26.
9
Long-term and sequential treatment for osteoporosis.骨质疏松症的长期和序贯治疗。
Nat Rev Endocrinol. 2023 Sep;19(9):520-533. doi: 10.1038/s41574-023-00866-9. Epub 2023 Jul 18.
10
Bone Mineral Density in Neurofibromatosis Type 1: A Systematic Review and Meta-Analysis.神经纤维瘤病 1 型的骨密度:系统评价和荟萃分析。
Calcif Tissue Int. 2023 Aug;113(2):166-174. doi: 10.1007/s00223-023-01094-z. Epub 2023 May 23.
Teriparatide Treatment in Patients with Pregnancy- and Lactation-Associated Osteoporosis.
特立帕肽治疗妊娠和哺乳期相关骨质疏松症患者。
Calcif Tissue Int. 2021 Nov;109(5):554-562. doi: 10.1007/s00223-021-00871-y. Epub 2021 Jun 16.
4
Bone Density After Teriparatide Discontinuation With or Without Antiresorptive Therapy in Pregnancy- and Lactation-Associated Osteoporosis.妊娠和哺乳期相关骨质疏松症停用特立帕肽后联合或不联合抗吸收治疗的骨密度。
Calcif Tissue Int. 2021 Nov;109(5):544-553. doi: 10.1007/s00223-021-00869-6. Epub 2021 May 26.
5
Musculoskeletal Health in Premature Ovarian Insufficiency. Part Two: Bone.卵巢早衰中的肌肉骨骼健康。第二部分:骨骼。
Semin Reprod Med. 2020 Sep;38(4-05):289-301. doi: 10.1055/s-0041-1722849. Epub 2021 Mar 30.
6
Bone quality assessed by trabecular bone score in severe anorexia nervosa: A brief report.严重神经性厌食症患者的骨小梁骨评分评估的骨质量:简要报告。
Int J Eat Disord. 2021 May;54(5):903-907. doi: 10.1002/eat.23506. Epub 2021 Mar 29.
7
The clinical features that contribute to poor bone health in young Australians living with cystic fibrosis: A recommendation for BMD screening.导致生活在澳大利亚的年轻囊性纤维化患者骨健康不良的临床特征:推荐进行骨密度筛查。
Pediatr Pulmonol. 2021 Jul;56(7):2014-2022. doi: 10.1002/ppul.25375. Epub 2021 Apr 1.
8
Positive Effect of Teriparatide on Areal Bone Mineral Density in Young Women with Anorexia Nervosa: A Pilot Study.特立帕肽对神经性厌食症年轻女性骨面积骨密度的积极影响:一项初步研究。
Calcif Tissue Int. 2021 May;108(5):595-604. doi: 10.1007/s00223-020-00791-3. Epub 2021 Jan 8.
9
Musculoskeletal Health in Premature Ovarian Insufficiency. Part One: Muscle.卵巢早衰中的肌肉骨骼健康。第一部分:肌肉
Semin Reprod Med. 2020 Sep;38(4-05):277-288. doi: 10.1055/s-0040-1721797. Epub 2021 Jan 8.
10
The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.依伐卡托对囊性纤维化患儿和成人骨密度及微结构的影响。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1248-e1261. doi: 10.1210/clinem/dgaa890.